FDA
approval
· 2024-06-17
FDA Approved: VIGAFYDE — Original Application (Upsher-Smith Laboratories, LLC)
Summary
FDA approves VIGAFYDE (vigabatrin) from Upsher-Smith in an original NDA; the product is indicated for certain seizure disorders, including infantile spasms and …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VIGAFYDE (VIGABATRIN)